The role of interleukin-6 in inhibition of lung metastasis in subcutaneous tumor-bearing mice

Oncol Rep. 2000 Jan-Feb;7(1):69-73. doi: 10.3892/or.7.1.69.

Abstract

Metastasis is the most important factor for prognosis in cancer patients, and its occurrence is largely associated with host immune response. We found that the presence of a growing tumor of colon 26, a mouse colon cancer cell line, completely inhibited lung colony formation in a mouse injected with colon 26 intravenously, whereas depletion of effector cells, such as natural killer and T cell subsets, did not affect antimetastasis of colon 26. Since colon 26 releases large amounts of interleukin-6 (IL-6) spontaneously, we studied the association of IL-6 with lung metastasis. Serum IL-6 level increased gradually and reached 12.6 pg/ml five days after inoculation of colon 26 in the back of mice, while at the same time, lung colony formation was inhibited. Moreover, expression of IL-6 mRNA in lung was observed to be associated with elevated serum IL-6 level. We show the first evidence that inhibition of lung metastases in tumor-bearing mice by colon 26 is closely associated with an increase in serum IL-6, but not in cellular immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Interleukin-6 / blood
  • Interleukin-6 / genetics
  • Interleukin-6 / physiology*
  • Lung Neoplasms / prevention & control*
  • Lung Neoplasms / secondary*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neoplasms, Experimental / immunology*
  • Rats
  • Skin Neoplasms / immunology
  • T-Lymphocytes / physiology
  • Tumor Cells, Cultured

Substances

  • Interleukin-6